Showing 8,461 - 8,480 results of 29,133 for search '(( 5 step decrease ) OR ( 50 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.01s Refine Results
  1. 8461

    Image_3_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  2. 8462

    Image_2_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  3. 8463

    Image_1_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  4. 8464

    Esculetin, a coumarin derivative, exerts in vitro and in vivo antiproliferative activity against hepatocellular carcinoma by initiating a mitochondrial-dependent apoptosis pathway by J. Wang (472325)

    Published 2019
    “…Esculetin significantly inhibited proliferation of HCC cells in a concentration- and time-dependent manner and with an IC50 value of 2.24 mM. …”
  5. 8465

    A regulatory gene network of foam-cell formation. by Josefin Skogsberg (88384)

    Published 2008
    “…CE accumulation (given as average percentage next to each node) was decreased (blue) by siRNA inhibition of 5 genes and increased (red) by inhibition of 2 genes; inhibition of 1 gene had no effect (black) (see also <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000036#pgen-1000036-t003" target="_blank">Table 3</a>). …”
  6. 8466
  7. 8467
  8. 8468

    Lithium Borate Containing Bifunctional Binder To Address Both Ion Transporting and Polysulfide Trapping for High-Performance Li–S Batteries by Lei Zhong (192135)

    Published 2019
    “…However, the capacity of the cathode using the PVDF binder decreased to 331 mAh g<sup>–1</sup> after 180 cycles at 0.5 C. …”
  9. 8469

    Lithium Borate Containing Bifunctional Binder To Address Both Ion Transporting and Polysulfide Trapping for High-Performance Li–S Batteries by Lei Zhong (192135)

    Published 2019
    “…However, the capacity of the cathode using the PVDF binder decreased to 331 mAh g<sup>–1</sup> after 180 cycles at 0.5 C. …”
  10. 8470

    Lithium Borate Containing Bifunctional Binder To Address Both Ion Transporting and Polysulfide Trapping for High-Performance Li–S Batteries by Lei Zhong (192135)

    Published 2019
    “…However, the capacity of the cathode using the PVDF binder decreased to 331 mAh g<sup>–1</sup> after 180 cycles at 0.5 C. …”
  11. 8471

    The impact of the single exit price policy on a basket of generic medicines in South Africa, using a time series analysis from 1999 to 2014 by Rajatheran Moodley (7109351)

    Published 2019
    “…</p><p>Results</p><p>Majority of the medicines analysed reflect a substantial decrease in medicine prices immediately after implementation of the pricing regulations as reflected in both the change in level and the change in slope using the interrupted time series analysis.…”
  12. 8472
  13. 8473

    Establishment and characterization of a choroid plexus barrier system. by Bethany A. O’Hara (8532741)

    Published 2024
    “…<p>A) Barrier development protocol. Cells are maintained at high density (>50% confluence) and used for experiments between passages 30–38. …”
  14. 8474

    RovA stimulated transcription of its own gene. by Yiquan Zhang (113213)

    Published 2011
    “…<p>Only the bacterial cells of “shift from 26 to 37°C” at the middle-exponential growth phase were analyzed herein. <b>a) LacZ fusion.</b> A promoter-proximal region 743 bp upstream to 146 bp downstream of <i>rovA</i> was cloned into pRW50 containing a promoterless <i>lacZ</i> reporter gene, and then transformed into WT or <i>ΔrovA</i> to determine the β-galactosidase activity in cellular extracts. …”
  15. 8475

    Change in smooth muscle NO from a dynamic increase in flow. by William Davis Haselden (9175156)

    Published 2020
    “…<p>Simulations were performed using a static proximal model with a NO production rate in the parenchyma of 0.02 M/s corresponding to 50% GC activity with no flow. …”
  16. 8476

    The physiological role of I<sub>Cl(Ca)</sub> during membrane depolarization was examined using NPPB and T16A<sub>inh</sub>-A01. by Ji Hyun Jeon (112239)

    Published 2013
    “…The half-maximal dose (EC<sub>50</sub>) of T16A<sub>inh</sub>-A01 that was necessary to increase the width was similar to EC<sub>50</sub> of T16A<sub>inh</sub>-A01 that inhibited I<sub>Cl(Ca)</sub> (2.6 vs. 3.0 µM). …”
  17. 8477
  18. 8478
  19. 8479
  20. 8480